Manufacturing

Kai Vogt is senior vice-president Corporate Development, Legal and Compliance, Information Technology at Vetter Pharma. 

Articles

CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects. 

Digitalization: A CDMO’s Perspective

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Data collected through the Industrial Internet of Things enable predictive maintenance.

Optimizing Machine Health

Chris O’Callaghan is senior product manager at Innopharma Technology, Dublin, Ireland, ocallaghanc@innopharmalabs.com.

Ian Jones, PhD, is founder and CEO of Innopharma Technology and Innopharma College of Applied Sciences, Dublin

Caroline McCormack  is process laboratory manager at Innopharma Technology, Dublin, Ireland.

Luke Kiernan is a PhD student at the Technological University Dublin in Ireland.

Gavin Walker, PhD, is professor and director of the Synthesis and Solid State Pharmaceutical Centre at the University of Limerick in Ireland.

Gareth Clarke is Multieye Product Manager, Innopharma Technology, Dublin,Ireland

Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.

Self-Guided Control of a Fluid Bed Granulation Process

Sartorius and the German Research Center for Artificial Intelligence have established a research laboratory for AI in the biopharmaceutical industry.

Sartorius and German Research Center Collaborate on Artificial Intelligence

Predictive and prescriptive maintenance improve pharmaceutical manufacturing equipment effectiveness. 

Data Analytics Technologies Help Reduce Equipment Failure

Agnes Shanley is senior editor of Pharmaceutical Technology.

Long a staple for quality by design and solid dosage form manufacturing, design of experiments is becoming an integral part of biopharma upstream process development.

Design of Experiments Gains Ground in Biopharma Development

As equipment evolves and use of PAT increases, DOE is becoming an integral part of upstream bioprocess development.


DOE Gains Ground in Biopharmaceutical Development

In batch production, efficient exception management means reducing the time required to identify, review, and resolve process exceptions. Incorporating review by exception functionality within manufacturing execution system (MES) software can streamline biopharmaceutical product release.


Review by Exception: Connecting the Dots

Matteo Pozzi, matteo.pozzi@jacobs.com, is an automation engineer at Jacobs.

Manrico Zani, manrico.zani@jacobs.com, is an automation engineer at Jacobs.

The pressure to improve operational technology performance combined with the rapid pace of technology change is driving adoption of new automation models in pharmaceutical manufacturing.

The Emergence of Operational Technology as a Service

Systems-based pharmaceutics case studies, challenges, and new uses were discussed at PSE’s Advanced Process Modeling Forum.

Process Control, Automation, and PAT